|Bid||2.8000 x 3200|
|Ask||2.7600 x 36900|
|Day's range||2.7500 - 2.9150|
|52-week range||2.6500 - 13.9500|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||6.55|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEW YORK, October 26, 2021--Tilray, Inc. ("Tilray") (NASDAQ | TSX: TLRY), a global pioneer in medical cannabis research, cultivation, production, and distribution, today announced it has been selected by the Luxembourg Ministry of Health as a supplier of Good Manufacturing Practice (GMP) certified medical cannabis products for the country’s medical cannabis program.
NEW YORK & TORONTO, October 20, 2021--Tilray, Inc. ("Tilray") (Nasdaq:TLRY; TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company and Great North Distributors, Inc. (Great North), Canada’s first national sales broker for legalized adult-use cannabis — today announced a signed national brokerage agreement with Tilray Canada Ltd. Under the agreement, Great North will be the exclusive representative for Tilray’s complete portfolio of adult-use cannabis products across t
NEW YORK & LEAMINGTON, Ontario, October 19, 2021--Tilray, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY; TSX: TLRY) announces the expansion of its leadership team with the appointment of Blair MacNeil as President, Tilray Canada. In his new role, Blair will drive Tilray’s next stage of growth in Canada and oversee sales, marketing, and operations across medical and adult-use cannabis businesses. Blair will report to Jim Meiers, who has been appointed to Chief Operations Officer, Tilray, Inc.